A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects.

Inclusion Criteria: * Subject has nutritional obesity and BMI \>30 kg/m Exclusion Criteria: * Type 1 or type 2 diabetes mellitus * Inadequately controlled hypertension * History of Gilles de la Tourette's Syndrome. * Use of any MAOIs, SSRIs, amino acids, antimigraine drugs, opioids * Hypothyroidism or hyperthyroidism. * History of: * benign prostatic hyperplasia * neurological disorders * psychiatric illness * severe renal or hepatic impairments * narrow-angle glaucoma * History of cardiovascular disease or cerebrovascular disease * Persistent tachycardia at rest * Pulmonary hypertension * Phaeochromocytoma